Joanna Horobin
Vermögen: 2 Mio $ am 31.10.2026
Vermögen: 2 Mio $ am 31.10.2026
Joanna C.
Horobin is currently an Independent Director at Liquidia Technologies, Inc. since 2019, an Independent Director at Liquidia Corp.
since 2020, and a Member of the Royal College of General Practitioners.
Former roles include Independent Director at Kymera Therapeutics, Inc. from 2018 to 2024, Independent Non-Executive Director at Nordic Nanovector ASA from 2016 to 2023, Independent Director at Vyant Bio, Inc. from 2021 to 2023, Chief Medical Officer & Senior Vice President at Idera Pharmaceuticals, Inc. from 2015 to 2019, Chief Medical Officer at Verastem, Inc. from 2012 to 2015, President & Director at Syndax Pharmaceuticals, Inc. in 2012, Executive Vice President at CASI Pharmaceuticals, Inc., Chief Operating Officer at CombinatoRx, Inc., Vice President-Oncology at Rhone-Poulenc Rorer, Inc., Director at Nascent Pharmaceuticals, Inc., Director at The University of Manchester, and Non-Executive Chairman at iOnctura SA. Education includes a doctorate from The University of Manchester.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0,04 % | 16.06.2026 | 39.637 ( 0,04 % ) | 2 Mio $ | 31.10.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| LIQUIDIA CORPORATION | Direktor/Vorstandsmitglied | 28.06.2020 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Direktor/Vorstandsmitglied | 11.09.2019 |
Royal College of General Practitioners
Royal College of General Practitioners Other Consumer ServicesConsumer Services College/University | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 18.06.2024 |
| VYANT BIO, INC. | Direktor/Vorstandsmitglied | 01.12.2023 |
| THOR MEDICAL | Direktor/Vorstandsmitglied | 03.01.2023 |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2019 |
| VERASTEM, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2015 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 15 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for treating cancer and inflammatory diseases | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
Nascent Pharmaceuticals, Inc.
Nascent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals & drugs | Health Technology |
Royal College of General Practitioners
Royal College of General Practitioners Other Consumer ServicesConsumer Services College/University | Consumer Services |
Verastem, Inc.
Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Nordic Nanovector ASA
Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
iOnctura SA
iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Health Technology |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Liquidia Corp.
Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Vyant Bio, Inc.
Vyant Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen